Importantly, pharmacologic MCC950-mediated inflammasome inhibition resulted in a significant increase in the spleen M-MDSCs and subsequent reduction of G-MDSCs as compared to the control-treated group (Figure 8D), recapitulating the results obtained in Nlrp3-/- tumor-inoculated animals. The gene discussed is NLRP3; the disease is neoplasm.